When thinking about valuing #biotechs, especially those which are not yet profitable, a probability adjusted discounted cash flow model is perhaps the most important methodology

Though it too has drawbacks

#DCF #PoS #learnbiotechinvesting #investing #BiotechPrometheus

Le Journal des #Biotechs : André Choulika, PDG de #Cellectis 🧬 revient sur les résultats marquants d'éti‑cel dans le #Lymphome 🩸 R/R & détaille la stratégie avec IL‑2
Il évoque les avancées sur #UCART22 🧬 & #UCART20_22 🧬 & donne les RDV importants de 26
www.boursorama.com/videos/actua...

From Cow-Free Dairy to Human Milk 2.0: Biotechs Race to Brew Breast Milk Proteins - Biotech Industry Examiner The first wave of “milk without cows” promised more sustainable cheese and ice cream. The next wave is far more ambitious – and politically fraught. Start-ups

#Biotechs are moving beyond cow-free dairy into Human Milk 2.0 – brewing breast milk proteins like lactoferrin in steel tanks for the US$90bn formula market. Science, economics, ethics all collide in our new explainer
biotech.industryexaminer.com/cow-free-dai...
#HumanMilk2_0 #BiotechNews #TechNews

If #AI is superior to human involvement in #drugdevelopment, why aren't more #biotechs using it?

Find out on the latest episode of the @biorasi.bsky.social Few and Far Between podcast, as host Chris O'Brien welcomes Justin Stebbing to the show >> youtu.be/-Yl0SG0cQJM

OMG : décodons les biotech | Ausha Le podcast OMG, décodons les biotech relate des enquêtes sur des biotechnologies encore méconnues. Ces dernières concernent aujourd'hui bien plus que les plantes génétiquement modifiées qui ont défray...

Et si on refaisait vivre le #mammouth laineux pour sauver la planète ? @infogm.bsky.social lance son nouveau #podcast d’enquête sur les #biotechs. Écoutez "OMG, Décodons les Biotech" sur toutes les plateformes de podcast : podcast.ausha.co/omg-decodons...

OMG : décodons les biotech | Ausha Le podcast OMG, décodons les biotech relate des enquêtes sur des biotechnologies encore méconnues. Ces dernières concernent aujourd'hui bien plus que les plantes génétiquement modifiées qui ont défray...

Et si on refaisait vivre le #mammouth laineux pour sauver la planète ? @infogm.bsky.social lance son nouveau #podcast d’enquête sur les #biotechs. Écoutez "OMG, Décodons les Biotech" sur toutes les plateformes de podcast : podcast.ausha.co/omg-decodons...

(1/2) 📢 NOTEZ LA DATE À VOTRE AGENDA! Un nouveau programme destiné aux #biotechs canadiennes de #MédecineRégénératrice va être lancé 🇨🇦

🔗 stemcellnetwork.ca/fr/recherche...

📢 SAVE THE DATE! A new program is coming, specific for Canadian #biotechs in #RegenerativeMedicine 🇨🇦

SCN’s Incubation Investment Award Program will support pre-seed & seed-staged RM companies with:
💰 $250K–$1M per company
⏳ 2–3 yrs, milestone-based tranches

🔗 stemcellnetwork.ca/research/inc...

"Revolutionizing skincare: Biotech advancements unlock new paths to glowing, healthy skin. From peptide-infused moisturizers to stem cell-derived serums, discover the latest innovations transforming the beauty industry #biotechs skincare #innovat... Cheap & High Quality Makeup: cutt.ly/FrRrWxtI

FDA unveils fast-track review path for 'national priorities' FDA Commissioner Marty Makary has revealed a new priority review voucher programme for new medicines deemed to be of national priority for the US

#USA #pharmaceuticals #FDA #fasttrackreviewpath #CommissionersNationalPriorityVoucherprogramme #CNPVprogramme #CNPV #unmetpublichealthneeds #domesticdrugmanufacturing #medicaldecisionmaking #FDApathways #priorityreviewvouchers #PRVs #orphandrugs #biotechs
pharmaphorum.com/news/fda-unv...

Strive Closes $750M Investment Deal to Power 'Alpha-Generating' Bitcoin Strategy Investment sets stage for $1.5 billion total proceeds and strategic bitcoin accumulation with alpha-generating focus

#AssetEntities so Vivek dilutes the heck out of it for $1.35M/share plus warrants and the stock still trades at $8+?

I beg all my under-cash trading #biotechs to fire all employees and start investing their cash in #bitoin. Seriously.

finance.yahoo.com/news/strive-...

Over 75 Biotech Companies Embrace Veeva Basics for Enhanced Clinical Efficiency Veeva Basics is being widely adopted by biotech companies, helping them optimize processes and save costs in clinical trials, regulatory, and quality management.

Over 75 Biotech Companies Embrace Veeva Basics for Enhanced Clinical Efficiency #None #Clinical_Trials #Veeva_Basics #Biotechs

If the coming months confirm such enhanced openess to AA (above+beyond Marks), then the long-shunned rare disease #biotechs need radical revaluation.

Who knows, even Big Pharma may get interested in space again.

At what point will #Chinese biotechs buy up Western #biotechs with critical tech and IP, incl #PrimeMedicine and #ProQR?

Executive Summary - Biotech Americans are already familiar with how the Chinese government conducts economic warfare with crucial technologies such as semiconductors: corner the supply chain, then choke it to weaken the United S...

In an effort to contain #China in #biotech, Congressional committee wants to encourage and provide investments into US #biotechs and have investigations into biotech dumping by China (this may affect Big Pharma licensing from China).

www.biotech.senate.gov/final-report...

Lowered #FDA regulatory approval standards does not immediately translate to poorer #reimbursement prospects.

#biotechs already practice today to design trials to get adequate reimbursement when EMA approval standard too low for that. e.g. #StokeTherapeutics and Dravet's.

2 positives for Western #biotechs from Trumpcession and Trump tariff war:

1) pharma will think twink before doing deals with Chinese biotechs

2) 10-year plummetting, now at 3.87%

BIO rings alarm bells over Trump's pharma tariffs US tariffs on goods coming from Europe, China, and Canada could have a major impact on the biopharma industry and medicines access, says BIO.

#pharmatariffs #biopharmasector #BiotechnologyInnovationOrganization #BIO #FDAapprovedproducts #biotechs #pharmaceuticalmanufacturing #outsourcing #BIOsurvey #pharmaindustry #EliLilly #JohnsonandJohnson #biomedicalresearch #patients #medicinemanufacturing
pharmaphorum.com/news/bio-rin...

Departure of #FDA CBER's Peter Marks marks peak uncertainty for sector that's near and dear to me.

OK, RIP scientific progress, but anti-establishment vibes could also boost dev-stage #biotechs... at least short/medium term.

Trump Administration Dialing Back Support for H.I.V. Prevention The move follows cuts to prevention and treatment efforts worldwide with the shuttering of U.S.A.I.D.

Reduce your investments in #biotechs exposed to #woke drugs.

This week it was HIV (since it affects mostly gays); key question for me is will they come after #orphan, genetic diseases next? #Eugenics anyone?

www.nytimes.com/2025/03/19/h...

Et suivez l'actualité des #OGM, #biotechs, #semences et #brevets sur @infogm.bsky.social, média francophone indépendant traitant de ces questions depuis 1999! 🧐

State announces grants to lure smaller biotechs - The Bos... The program will offer grants to small life sciences comp...

MA announces grants to lure smaller #Biotechs www.bostonglobe.com/business/2016/06/07/stat... via @BostonGlobe

"do Monsanto Top People eat Monsanto products ?" oh wait .... #biotechs #hypocrite